Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

PPD Paid $77 Million to Acquire BioDuro

publication date: Nov 30, 2009
In reporting that it has closed its acquisition of BioDuro, PPD, Inc. announced it paid $77 million for BioDuro. The price was not previously released, nor has PPD disclosed the annual revenues of privately held BioDuro. PPD did say that, post-acquisition, it has nearly 1,000 employees in China. Of these, almost 660 came from BioDuro. The company now claims to be the largest CRO in China offering both clinical development and discovery services. More details...
Stock Symbol: (NSDQ: PPDI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital